Newscast – Page 145 – media

US FDA grants Breakthrough Therapy Designation for Roche’s Alecensa (alectinib) for first-line treatment of people with ALK-positive NSCLC

The latest BTD was granted for the treatment of adult patients with advanced anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) who have not received prior treatment with an ALK inhibitor.
- Source: Roche
- 589
- November 23, 2017
anaplastic lymphoma kinase Company Insight FDA non-small cell lung cancer Roche
Using digital pills, researchers find patients consume fewer opioids than expected

The team found that most participants opted to use opioids during the first three days following discharge from the emergency department and that on average, patients took just six pills, despite being given 21.
- Source: Drugdeliverybusine
- 440
- November 23, 2017
etectRx‘s ID-Cap system opioid Researches
China makes use of AI for healthcare

An estimated 300 million Chinese people are smokers. China has also a serious issue with hazardous air pollution. Here concentrations of small, breathable particles (PM2.5) invariably exceeding 300 micrograms per cubic meter in the industrialized northern regions.
- Source: digitaljournal
- 682
- November 23, 2017
Artificial Intelligence China healthcare lung cancer
DEATH ROW Madagascar plague doctors say infections have reached ‘crisis point’ as Black Death toll hits 195

In less than one week, there has been a three per cent rise in casualties, as more 2,267 people have been struck with the disease, according to official WHO figures.
- Source: thesun.co.uk
- 525
- November 23, 2017
Black Death Madagascan Researches
How do cancer cells start to spread? Study sheds light

Metastatic cancer is responsible for the vast majority of cancer deaths, but our limited understanding of how metastasis begins makes finding ways to stop it hugely challenging. A new study may provide some insight, however.
- Source: medicalnewstoday
- 506
- November 23, 2017
cancer Researches
Study shows how gut bacteria may trigger MS

Alterations in gut bacteria at a young age could help to trigger and progress multiple sclerosis in people who are genetically predisposed to the autoimmune disease.
- Source: medicalnewstoday
- 521
- November 22, 2017
multiple sclerosis Researches
Study reveals what depression, anxiety look like in the brain

People with depression and social anxiety have some common and specific structural abnormalities in their brains that can be spotted in imaging scans.
- Source: drugdu
- 535
- November 22, 2017
Depression Researches
Meeting the Internet of Medical Things’ Demands for Networking

More connected medical devices are coming online every day, reshaping the way that healthcare networks are designed, used and secured.
- Source: healthtechmagazine.net
- 476
- November 22, 2017
Internet of Things Researches
Stanford, NCI Researchers Discover New CAR-T Target With Early Study Data

Researchers at Stanford University School of Medicine with the National Cancer Institute (NCI) have identified another cancer-surface molecule, CD22, and begun trials on B-cell acute lymphoblastic leukemia (ALL) patients using an immuno-oncology approach similar to CAR-T. In the Phase I trial, 15 of the 21 patients who had previously relapsed or did not respond to anti-CD19 CAR-T, were treated with an anti-CD22 CAR-T therapy. Ten of the 15 patients had already received treatment for CD19-targeted treatment.
- Source: biospace
- 595
- November 22, 2017
cancer CAR–T immuno-oncology Researches
FDA approves first two-drug regimen for certain patients with HIV

The U.S. Food and Drug Administration(FDA) today approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs included in standard HIV treatment.
- Source: finance.yahoo
- 503
- November 22, 2017
FDA HIV immunodeficiency Juluca New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.